Get startedLog in
    Picture of Essex Bio-Technology logo

    1061 — Essex Bio-Technology Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Essex Bio-Technology, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line251394260346376
    Depreciation
    Amortisation
    Non-Cash Items-13.23337.63.63-6.99
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital34.4-50.843.3-70-55.6
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Other Operating Cash Flow
    Cash from Operating Activities299409383339368
    Capital Expenditures-330-255-283-128-119
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-13.3-25.2-19.173.712.9
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-343-280-302-54.3-107
    Financing Cash Flow Items-8.64-12.3-15.7-15.9-63.6
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities149-73.1-169-310-201
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash12671.6-128-33.647.3